PRAC september 2026: veiligheidsonderzoek naar injecteerbare ijzerhoudende geneesmiddelen

Imported from official source

During its September 2026 meeting, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has started the review of injectable iron-containing medicines. The review will assess the risk of low blood phosphate levels and related bone problems with injectable iron medicines. …

This version

Version
1 of 1
Recorded
October 03, 2026 20:37
Change
Initial
Content hash
887e1b18769341f5239028a3605112ff
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.